FDA to Review Topical Psoriasis Treatment for Young Children FDA to Review Topical Psoriasis Treatment for Young Children

Roflumilast cream 0.3% was approved for treating psoriasis in adolescents and adults in July.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news